Recent Developments in Convenience of Administration of the Anti-CD38 Antibody Isatuximab: Subcutaneous Delivery and Fast Intravenous Infusion in Patients With Multiple Myeloma

  1. Quach, H.
  2. Parmar, G.
  3. Mateos, M.-V.
  4. Ailawadhi, S.
  5. Leleu, X.
Revista:
Clinical Lymphoma, Myeloma and Leukemia

ISSN: 2152-2669 2152-2650

Año de publicación: 2024

Tipo: Revisión

DOI: 10.1016/J.CLML.2024.02.004 GOOGLE SCHOLAR